Life Stem Genetics Inc (LIFS)

[RPicks]

Don't say I didn't try to warn you.

[stoxrock]

Off by One Day: This is a Signal Top on Volume Signature

[RPicks]

Awful quiet around here

[RPicks]

If he has done thousands there should be evidence other than we said so

[RedShoulder]

The future of LIFS depends on their execution of the business plan, based on the two LOI's within weeks of being listed speaks volumes. Once these LOIs become trained and operable, the revenues will start.

[RedShoulder]

Mr. Bosch has done thousands of stem cell treatments, and has other leadership experiences. He will do the training, and should be able to accomplish that based on experience. Once staff is trained in these clinics, the revenues should commence.

[RPicks]

Look what is happening to VEND right now!

This is a stocked pumped by one of the people pumping LIFS

[RPicks]

Not a very impressive BIO For Vanden Bosch 15 years and he has two bachelors and two associates from two low level universities and colleges. If he is so well published you would think that you could find out about him on a website that wasn't sponsored by himself of LIFS

[RedShoulder]

There is no SEC investigation in this purely speculative rag article by 'Hot Stocked'. No SEC regulations have been violated.

[RPicks]

SEC Investigation coming?

http://www.hotstocked.com/article/69472/life-stem-genetics-inc-otcbb-lifs-s-pump-is.html

[RedShoulder]

Adding this to the DD in the previous post:

LIFS Home Page:
http://www.lifestemgenetics.com/

[RedShoulder]

Due Dilligence for LIFS:

(Keep in mind this issue is only one month old).

LOI with 25 clinics in Canada:

http://finance.yahoo.com/news/life-stem-genetics-announces-loi-133000441.html

LOI South East Asia:

http://finance.yahoo.com/news/life-stem-genetics-announces-loi-133000387.html

Closes private placement for $1.00 per unit per agreement at start up of this new issue:

http://finance.yahoo.com/news/life-stem-genetics-announces-closing-133000320.html

The man who will be the 'Chief Medical Stem Cell Specialist' with thousands of stem cell treatments as expert experience. Will also do the training.

http://finance.yahoo.com/news/life-stem-genetics-announces-james-143700343.html

New issue LIFS as of Oct 17th:

http://finance.yahoo.com/news/life-stem-genetics-stock-symbol-164700364.html

Bullish Chart:

http://stockcharts.com/h-sc/ui?s=LIFS&p=D&b=5&g=0&id=p40975096012

----end DD ----

LIFS has accomplish much in just one month since listing, obviously a lot of good groundwork and contacts made before the listing. Excellent start for this new issue.

[TechnoAnalyst]

Hey guys, whats going on here?

[RedShoulder]

Bullish LIFS Chart:

http://stockcharts.com/h-sc/ui?s=LIFS&p=D&b=5&g=0&id=p40975096012

Bollinger Bands opening up to bloom, very bullish looking chart on this new issue only a month old, good to be in early.

It sold off in the first half hour down to $1.63 on 250K sell, bounced right back within minutes to print a new all time high, printing $1.82 as I post this. Stock is strong. A PR on the 25 clinics in Canada should send this flying, ...we'll see.

[stoxrock]

RANGE SQUARE OUT ON SIGNAL BAR (top reversal, vol signature)

its ova

[kyle_anderson]

LIFS about to get some action.

O/S: 44,537,500 (a/o October 23, 2013)
A/S: 250,000,000 (a/o October 23, 2013)

Good luck

[RedShoulder]

"The net proceeds from the private placement will be used primarily to attract additional affiliate clinics both in the United States and internationally and also for investment in various joint ventures under development ultimately moving our company’s growth initiatives forward.”

http://finance.yahoo.com/news/life-stem-genetics-announces-closing-133000320.html

[RedShoulder]

Good News! LIFS Life Stem Genetics Announces the Closing of Its Previously Announced $1 Million Private Placement

Life Stem Genetics, Inc. (OTCBB:LIFS) (the “Company”) is pleased to announce yesterday’s closing of its previously announced private placement. The financing is for $1.0 million (the “Private Placement”) of 1,000,000 units (each, a “Unit”) at a price of $1 per Unit.

As previously detailed, each Unit of the private placement consists of one common share of the Company and one warrant to purchase an additional common share of the Company (each, a “Warrant Share”) at $1 per Warrant Share for a period of one year. If and when all of the warrants are exercised, the Company will realize up to an additional $1.0 million in proceeds.

Gloria Simov, President and CEO of Life Stem Genetics, commented, "We are pleased to have closed the financing which reflects investor confidence in the strength of our Adult Stem Cell (ASC) clinic-based business model. The net proceeds from the private placement will be used primarily to attract additional affiliate clinics both in the United States and internationally and also for investment in various joint ventures under development ultimately moving our company’s growth initiatives forward.”

About Life Stem Genetics

Life Stem Genetics ("LSG") is a progressive healthcare company focused on Adult Stem Cell (ASC) healing therapies. For decades, stem cells have been utilized in the successful treatment of a variety of ailments. Today, advanced ASC therapies are being offered to patients as an efficient and painless alternative treatment for a wide range of ailments including, but not limited to, orthopedic injuries, neurological disorders such as Parkinson's and Alzheimer's, cancer, arthritis, diabetes, multiple sclerosis, as well as age management. Adult Stem Cell therapies and LSG's proprietary techniques are experiencing some of the best results in the industry in helping to repair or reprogram damaged or diseased tissues and organs. Life Stem's ASC specialist has performed thousands of stem cell treatments including some of the top names in PGA golf, NFL football, NBA basketball, and Major League Baseball. LSG will offer its proprietary treatments through a series of affiliate doctors and medical clinics with 60 affiliated clinics thus far. LSG's mission is to develop a comprehensive approach to the treatment and maintenance of diseases while breaking free from the medical insurance maze by tapping into an affordable private-pay sector.

Contrarian Press, an established publisher, has been engaged by Life Stem Genetics to assist with identification of potential market participants who may be interested in learning more about the company and its securities. Updated disclaimer and disclosure information is available at the publisher's website and at the following link:

http://www.contrarianwealthcoalition.com/guide/LIFS.pdf

Yahoo Financial News Link:

http://finance.yahoo.com/news/life-stem-genetics-announces-closing-133000320.html

[Chatee]

Here is a bio on James VandenBosch:
http://www.jboschconsulting.com/about.htm

[RPicks]

It has been more than ten days and they still have not said who the LOI is with in Canada.

[wreckingball]

I'm new to this stock. I see a lot of potential. Hi all

[RedShoulder]

This new issue is just now a month old from their new listing, of course there are no revenues yet. However in that short time of just weeks they have signed two LOIs for stem cell treatments in their clinics. In just two weeks Mr. Bosch will start.

Quoted is older quarters of a more or less shell company that they took over and then filed as a new listing with the new company stem cell business plan.

As a shareholder I am pleased with the fast pace of developments of this new issue in the high growth field of stem cell treatments.

New listing Oct 17th:

http://finance.yahoo.com/news/life-stem-genetics-stock-symbol-164700364.html

Shell is Miami Day Corp.

http://biz.yahoo.com/e/130903/midy8-k.html

[RPicks]

Funny! If Mr. Vanden Bosch is so famous and well published why does a search for him not bring up any of his articles. I could not find a single one. He is not even an MD!

I did find this:

What’s the Catch with Life Stem Genetics Inc? According to various disclosures, a transaction of $35k has or will occur to mention Life Stem Genetics in various investment newsletters. Last Friday, Life Stem Genetics announced that its Regenerative Specialist, James Vanden Bosch, BHA, had been given the title and responsibility of Chief Medical Stem Cell Specialist at Life Stem Genetics. In addition and last Wednesday, Life Stem Genetics announced the signing of a Letter of Intent between Life Stem Genetics, Inc. and Dr. Iqram Rahman in Dhaka, Bangladesh where both parties will enable LIFS to provide stem cell therapy to individuals who would derive benefit from such treatments using the company’s procedures and practices; while a week earlier, the company announced the signing of a Letter of Intent with a “soon to be disclosed” health and wellness chain in Canada with the announcement of the organization set to take place in approximately 10 days upon signing of the definitive agreement. Apparently, the undisclosed health and wellness chain operates in excess of 25 health/medical clinics throughout Canada. A quick look at Life Stem Genetics’ financials reveals no revenues; net losses of $16k (most recent reported quarter), $10k, $3k and $9k for the past four quarters; and no cash to cover $22k in current liabilities at the end of July. So perhaps investors should wait for the recently announced Letter of Intents to generate revenues.

[RedShoulder]

It appears that orthopedic injuries will be a significant percentage of the revenues. Since orthopedic injuries is a common medical issue, there should be plenty of clients. Age management also has a promising future using stem cell treatments.

----snip------

"Life Stem Genetics ("LSG") is a progressive healthcare company focused on Adult Stem Cell (ASC) healing therapies. For decades, stem cells have been utilized in the successful treatment of a variety of ailments. Today, advanced ASC therapies are being offered to patients as an efficient and painless alternative treatment for a wide range of ailments including, but not limited to, orthopedic injuries, neurological disorders such as Parkinson's and Alzheimer's, cancer, arthritis, diabetes, multiple sclerosis, as well as age management."

-----end snip-----

Looks like Mr Bosch with the experience of administering thousands of stem cell treatments, will be the lead trainer to physicians and clinicians in JV clinics around the world. Note the Dec 1st date, just two weeks away :

-----snip-----

Regenerative Specialist, James Vanden Bosch,BHA, has been given the title and responsibility of Chief Medical Stem Cell Specialist at Life Stem Genetics. Mr. Vanden Bosch has been in healthcare for more than a decade and has performed thousands of stem cell treatments on patients. Mr. Vanden Bosch is an accomplished speaker and premier expert in regenerative and stem cell treatments and is an author and publisher of articles to major Medical News Journals on subjects of Orthopedics, Autoimmune, and Neurological conditions.

Earlier this year the Company formalized an agreement with Vanden Bosch, and Bosch Consulting, both of West Palm Beach, FL., as a Corporate Advisor. Mr. Vanden Bosch will now be responsible for training the Company’s affiliate physicians, clinicians, and nursing staff, as well as, performing stem cell therapies at the Company’s locations around the world effective December 1, 2013.

About James Vanden Bosch

James Vanden Bosch has spent the last seven years specializing in Regenerative Medicine. He is specially trained in the development of Platelet Rich Plasma, Bone Marrow aspirate Concentrate, and Isolating of Human Adult Adipose Stem Cells. Having assisted in the performance of thousands of procedures, James is recognized as one of the top specialist in teaching and collaborating with physicians. He comes highly recommended by Stem Cell companies and physicians in educating and training medical professionals and their staff with the most up to date techniques. Additionally, James Vanden Bosch is a author and publisher of articles to major Medical news Journals on subjects of Orthopedics, Autoimmune, and Neurological conditions.

-----end snip-----

Full News Link:

http://finance.yahoo.com/news/life-stem-genetics-announces-james-143700343.html

[Chatee]

One of my relatives just got stem cell treatments for cancer.
It sounds good. I don't know whether to invest more.

[Marilynt]

I have a 529 account for my stepdaughter and am wondering if the brokerage firm gave it to them. They probably did. Might have sold it to them.

I see that LIFS has moved up a little recently. Maybe they're staggering the flyers to keep up the momentum. I hope so for the sake of investors. Since my last name starts with a "T" which is near the end of the alphabet, they might be near the bottom of their list. Of course, that might be the case.

[sinjohn221]

I have never figured that out.

[Marilynt]

I received a flyer today. I wonder how they get mailing addresses.

[RedShoulder]

Bullish chart, closed on the high of the day, and the 'all time high' of this new issue:

http://stockcharts.com/h-sc/ui?s=LIFS&p=D&b=5&g=0&id=p40975096012

Note on the chart the fast approaching upper bollinger band share price target of $1.72, which appears to become history in very short order when looking a the projected intersection curve of the SP to the upper band curve. We will see if so soon enough.

Next week should be intersting. As a shareholder I am very pleased with the fast pace of the roll out of thier business plan, obviously a lot of pre ground work had already been laid before the company became listed. Excellent PRs this week, especially the two LOIs for a listing less than a month old. Revenue potential with LIFS is huge if they can execute their business plan ...so far so good with the two LOIs in less than a month.

Congrats on the gains so far to all new shareholders.

[RedShoulder]

"Mr. Vanden Bosch has been in healthcare for more than a decade and has performed thousands of stem cell treatments on patients. Mr. Vanden Bosch is an accomplished speaker and premier expert in regenerative and stem cell treatments and is an author and publisher of articles to major Medical News Journals on subjects of Orthopedics, Autoimmune, and Neurological conditions."

[RedShoulder]

News, 'LIFS Announces James Vanden Bosch as Chief Medical Stem Cell Specialist'


1 hour ago

BEVERLY HILLS, Calif.--(BUSINESS WIRE)--

Life Stem Genetics, Inc. (LIFS.OTCBB) (the “Company”) announces that its Regenerative Specialist, James Vanden Bosch,BHA, has been given the title and responsibility of Chief Medical Stem Cell Specialist at Life Stem Genetics. Mr. Vanden Bosch has been in healthcare for more than a decade and has performed thousands of stem cell treatments on patients. Mr. Vanden Bosch is an accomplished speaker and premier expert in regenerative and stem cell treatments and is an author and publisher of articles to major Medical News Journals on subjects of Orthopedics, Autoimmune, and Neurological conditions.

Earlier this year the Company formalized an agreement with Vanden Bosch, and Bosch Consulting, both of West Palm Beach, FL., as a Corporate Advisor. Mr. Vanden Bosch will now be responsible for training the Company’s affiliate physicians, clinicians, and nursing staff, as well as, performing stem cell therapies at the Company’s locations around the world effective December 1, 2013.

About James Vanden Bosch

James Vanden Bosch has spent the last seven years specializing in Regenerative Medicine. He is specially trained in the development of Platelet Rich Plasma, Bone Marrow aspirate Concentrate, and Isolating of Human Adult Adipose Stem Cells. Having assisted in the performance of thousands of procedures, James is recognized as one of the top specialist in teaching and collaborating with physicians. He comes highly recommended by Stem Cell companies and physicians in educating and training medical professionals and their staff with the most up to date techniques. Additionally, James Vanden Bosch is a author and publisher of articles to major Medical news Journals on subjects of Orthopedics, Autoimmune, and Neurological conditions.

About Life Stem Genetics

Life Stem Genetics ("LSG") is a progressive healthcare company focused on Adult Stem Cell (ASC) healing therapies. For decades, stem cells have been utilized in the successful treatment of a variety of ailments. Today, advanced ASC therapies are being offered to patients as an efficient and painless alternative treatment for a wide range of ailments including, but not limited to, orthopedic injuries, neurological disorders such as Parkinson's and Alzheimer's, cancer, arthritis, diabetes, multiple sclerosis, as well as age management. Adult Stem Cell therapies and LSG's proprietary techniques are experiencing some of the best results in the industry in helping to repair or reprogram damaged or diseased tissues and organs. Life Stem's ASC specialist has performed thousands of stem cell treatments including some of the top names in PGA golf, NFL football, NBA basketball, and Major League Baseball. LSG will offer its proprietary treatments through a series of affiliate doctors and medical clinics with 60 affiliated clinics thus far. LSG's mission is to develop a comprehensive approach to the treatment and maintenance of diseases while breaking free from the medical insurance maze by tapping into an affordable private-pay sector.

Contrarian Press, an established publisher, has been engaged by Life Stem Genetics to assist with identification of potential market participants who may be interested in learning more about the company and its securities. Updated disclaimer and disclosure information is available at the publisher's website and at the following link: http://www.contrarianwealthcoalition.com/guide/LIFS.pdf

[RedShoulder]

LIFS news PR should be released next week on the LOI that they have with the 25 clinics, be looking for a definative agreement signing per their PR on the LOI:

'Life Stem Genetics Announces LOI with a Chain of Health Clinics across Canada'

----snip -----

November 7, 2013 8:30 AM

BEVERLY HILLS, Calif.--(BUSINESS WIRE)--

Life Stem Genetics, Inc. (LIFS) announces the signing of a Letter of Intent (“LOI”) between Life Stem Genetics, Inc. and a soon to be disclosed health and wellness chain in Canada (“Company”). The announcement of the organization is set to take place in approximately 10 days upon signing of the definitive agreement.

The LOI between both parties will enable the company to provide stem cell therapy to individuals who would derive benefit from such treatments using LSG’s procedures and practices.

The company operates in excess of 25 health/medical clinics in various locations throughout Canada. Qualified LSG stem cell therapists will work with the company’s medical doctors in administering the therapy.

---END SNIP------

Full PR Link:
http://finance.yahoo.com/news/life-stem-genetics-announces-loi-133000441.html

The 10 days will be up this Sunday, looking for an update PR next week for the 'definitive agreement'.

This new issue of less than a month, is quickly executing the business plan of opening markets world wide of signing JVs with medical clinics for stem cell treatments. Stem cells are an important segment of future medical treatments.

LIFS business plan will be to generate 'significant' revenues per clinic, and to expand the market world wide - and they are off to a good start with two LOIs within weeks of the start up of this new issue.

[RPicks]

Is this the beginning of the DUMP?

Is this the time everyone runs for cover?

Who are the big winners?

[RPicks]

I hold no position in this stock.

If I can find somebody to loan me the shares I may short it.

[RPicks]

I still don't get it.

How much do they have left to do anything when they paid Contrarion Press to pump the stock. Then there is the issue of the very expensive web page and yet they can only afford to pay their CEO $30,000.00 per annum.

This reeks of trouble.

[RedShoulder]

LIFS is a new issue as of Oct 19th, I think they did a good job of financing at $1.00 per unit at the start up. Someone is financing cash with inside information, and apparently have a lot of confidence that their business plan will succeed.

LOS ANGELES--(BUSINESS WIRE)--

Life Stem Genetics (LIFS) is pleased to announce that it has completed and received the first $500,000 of the recently announced $1mm Private Placement. Our company is very happy to receive the first half of our recent private placement and hopes to close the additional $500,000 in the coming weeks.

The money will be used to attract additional affiliate offices country wide and to invest in various areas of research and development in moving our company's plans forward.

http://finance.yahoo.com/news/life-stem-genetics-pleased-announce-133000301.html

-------------------

They have begun to execute the business plan, a LOI with 25 medical clinics in Canada has been completed and an update due next week:

http://finance.yahoo.com/news/life-stem-genetics-announces-loi-133000441.html
-------------------

Then they continued to execute the business plan by signing another LOI in South Asia:

http://finance.yahoo.com/news/life-stem-genetics-announces-loi-133000441.html
-------------------

All of these positive developments from a new issue in less than a month. As a shareholder I am very pleased with the fast pace of developing their business plan that goal is to generate high revenues per health clinic.

Stem cell treatments have an important role in the future of health care. I think they are in the right field, and will generate significant revenues.

[RPicks]

I don't get it!

This is a company with ZERO revenue 1 paid employee and a monthly rent of $200 in Beverly Hills. Office must be a closet.

No R&D dollars. the only development they have done is paid Contrarion Press $300,000.00 to pump their stock.

http://www.hotstocked.com/article/68482/life-stem-genetics-inc-otcbb-lifs-just.html

http://www.hotstocked.com/article/68872/life-stem-genetics-inc-otcbb-lifs-marches-on.html

This is a stock destined for zero.

Look at the following numbers from their 8-K

ASSETS


Current assets:

Cash
$ 192
Total current assets
192

Total assets
$ 192


LIABILITIES AND STOCKHOLDERS' EQUITY


Current liabilities:

Accounts payable - related party
$ 120,000
Accrued executive compensation - related party
15,000
Notes payable - related party
4,329
Total current liabilities
139,329

Total liabilities
139,329



Total liabilities and stockholders' equity
$ 192

$192.00 for a 70 million dollar company. Really?

[RedShoulder]

Check out the Bullish chart on this new issue LIFS:

http://stockcharts.com/h-sc/ui?s=LIFS&p=D&b=5&g=0&id=p40975096012

Good to be in early on this new issue, my five buys so far have been an average up, the best kind of averaging (position making money).

According to this PR, shareholders should get an update on the 25 clinics they will JV with in Canada next week. The 10 days will be up this Sunday.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=93834797

According to their business plan the projected revenue per clinic is mind boggling, even a small percentage of that projection is a huge amount of revenue per clinic. The Canadian JV has 25 medical clinics.

Good to be in early before the revenues start rolling in and having a significant effect on the share price.

[RedShoulder]

Good News LIFS - Life Stem Genetics Announces LOI with Stem Cell Therapy Clinic in Dhaka, Bangladesh

HILLS, Calif.--(BUSINESS WIRE)--

Life Stem Genetics, Inc. (OTCBB:LIFS) (the“Company”) announces the signing of a Letter of Intent (“LOI”) between Life Stem Genetics, Inc. and Dr. Iqram Rahman (“IR”) in Dhaka, Bangladesh.

The pending agreement between the parties will enable the Company to provide stem cell therapy to individuals who would derive benefit from such treatments using LSG’s procedures and practices. The addition of LSG’s therapies to the clinic’s existing line-up of wellness procedures will undoubtedly be a significant asset in attracting and retaining patients in this South Asian megacity of more than 15 million people - 9th largest in the world .

“This LOI represents another step forward in our company’s business plan to continue implementing our ASC therapy services in established clinics throughout the world,” commented Life Stem Genetics President and CEO, Gloria Simov. “Asia’s aging population as a whole presents numerous age-related health challenges, of which ASC therapies hold great promise, and we are excited to bring our stem cell treatment methodologies to this part of the world.”

About Life Stem Genetics

Life Stem Genetics ("LSG") is a progressive healthcare company focused on Adult Stem Cell (ASC) healing therapies. For decades, stem cells have been utilized in the successful treatment of a variety of ailments. Today, advanced ASC therapies are being offered to patients as an efficient and painless alternative treatment for a wide range of ailments including, but not limited to, orthopedic injuries, neurological disorders such as Parkinson's and Alzheimer's, cancer, arthritis, diabetes, multiple sclerosis, as well as age management. Adult Stem Cell therapies and LSG's proprietary techniques are experiencing some of the best results in the industry in helping to repair or reprogram damaged or diseased tissues and organs. Life Stem's ASC specialist has performed thousands of stem cell treatments including some of the top names in PGA golf, NFL football, NBA basketball, and Major League Baseball. LSG will offer its proprietary treatments through a series of affiliate doctors and medical clinics with 60 affiliated clinics thus far. LSG's mission is to develop a comprehensive approach to the treatment and maintenance of diseases while breaking free from the medical insurance maze by tapping into an affordable private-pay sector

[RedShoulder]

This announcement was on Nov 7th. Next week we should here about the organization they are JVing with, which has 25 medical clinics.

http://finance.yahoo.com/news/life-stem-genetics-announces-loi-133000441.html

These 25 medical clinics should generate a significant amount of new revenue.

[sinjohn221]

Got a flyer in my mail box today, that says it all. Filed in the round shaped container. I decided to save my money and buy a coke, at least I can belch the gas away and not end up with a headache.

[andrewv]

What the heck caused that dip? Trade volume doesnt seem to explain it, heavy buying day, with no large sells.

[RedShoulder]

I've had to average up on every buy since my entry - nice. Good Luck andrewv on your future buys.

[andrewv]

Ive been following this for the past few weeks and finally took an entry position. UP UP UP UP. The growth in value is outstanding!!!!

[RedShoulder]

"Letter of Intent (“LOI”) between Life Stem Genetics, Inc. and a soon to be disclosed health and wellness chain in Canada (“Company”). The announcement of the organization is set to take place in approximately 10 days upon signing of the definitive agreement."

That announcement was on Nov 7th. Next week we should here about the organization they are JVing with, which has 25 medical clinics.

Averaging up again here, looking forward to the clinics bringing in significant revenue.

http://finance.yahoo.com/news/life-stem-genetics-announces-loi-133000441.html

[ThePennyDoctor]

Yeah, $1.27 close would have been better. Lets see if it can open there.

[Big_Money_Upward]

they managed to get 100k volume out of one hour of trading today, thats pretty good...it'd be more impressive if it went up ...

[RedShoulder]

FWIW, adding here on this good news:

"“Aside from instant growth in the Canadian market, this opportunity will allow us to realize immediate revenue in our business model.”

"The company operates in excess of 25 health/medical clinics in various locations throughout Canada"

http://finance.yahoo.com/news/life-stem-genetics-announces-loi-133000441.html

[RedShoulder]

Good News LIFS "Life Stem Genetics Announces LOI with a Chain of Health Clinics across Canada"

BEVERLY HILLS, Calif.--(BUSINESS WIRE)--

Life Stem Genetics, Inc. (LIFS) announces the signing of a Letter of Intent (“LOI”) between Life Stem Genetics, Inc. and a soon to be disclosed health and wellness chain in Canada (“Company”). The announcement of the organization is set to take place in approximately 10 days upon signing of the definitive agreement.

The LOI between both parties will enable the company to provide stem cell therapy to individuals who would derive benefit from such treatments using LSG’s procedures and practices.

The company operates in excess of 25 health/medical clinics in various locations throughout Canada. Qualified LSG stem cell therapists will work with the company’s medical doctors in administering the therapy.

“This news is very exciting for our organization as it allows us instant penetration into the Canadian market through a significant number of locations,” says Life Stem Genetics President and CEO, Gloria Simov. “Aside from instant growth in the Canadian market, this opportunity will allow us to realize immediate revenue in our business model.”

About Life Stem Genetics

Life Stem Genetics ("LSG") is a progressive healthcare company focused on Adult Stem Cell (ASC) healing therapies. For decades, stem cells have been utilized in the successful treatment of a variety of ailments. Today, advanced ASC therapies are being offered to patients as an efficient and painless alternative treatment for a wide range of ailments including, but not limited to, orthopedic injuries, neurological disorders such as Parkinson's and Alzheimer's, cancer, arthritis, diabetes, multiple sclerosis, as well as age management.

Adult Stem Cell therapies and LSG's proprietary techniques are experiencing some of the best results in the industry in helping to repair or reprogram damaged or diseased tissues and organs. Life Stem's ASC specialist has performed thousands of stem cell treatments including some of the top names in PGA golf, NFL football, NBA basketball, and Major League Baseball.

LSG will offer its proprietary treatments through a series of affiliate doctors and medical clinics with 60 affiliated clinics thus far. LSG's mission is to develop a comprehensive approach to the treatment and maintenance of diseases while breaking free from the medical insurance maze by tapping into an affordable private-pay sector.

Contrarian Press, an established publisher, has been engaged by Life Stem Genetics to assist with identification of potential market participants who may be interested in learning more about the company and its securities. Updated disclaimer and disclosure information is available at the publisher's website and at the following link:

http://www.contrarianwealthcoalition.com/guide/LIFS.pdf

Yahoo Finance News Link:

http://finance.yahoo.com/news/life-stem-genetics-announces-loi-133000441.html

[ThePennyDoctor]

I had been watching this one for a bit - started getting e-mails on it today from Trade of the Week [[e-mail]] - I didn't even know I was on this list.